| Vijaya Somaraju, MD | |
|
1905 E. Huebbe Parkway, Beloit Clinic, Beloit, WI 53511-1842 | |
| (608) 364-2240 | |
| (608) 363-7374 |
| Full Name | Vijaya Somaraju |
|---|---|
| Gender | Female |
| Speciality | Infectious Disease |
| Experience | 42 Years |
| Location | 1905 E. Huebbe Parkway, Beloit, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033187216 | NPI | - | NPPES |
| 036097724 | Medicaid | IL |
| Facility Name | Location | Facility Type |
|---|---|---|
| Osf Saint Anthony Medical Center | Rockford, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Osf Multi-specialty Group | 3678889789 | 1543 |
News Archive
Researchers at the University of Chicago have developed the first truly accurate mouse model of celiac disease. The animals have the same genetic and immune system characteristics as humans who develop celiac after eating gluten. This provides a vital research tool for developing and testing new treatments for the disease.
Alejandro Fuertes-Saiz, fourth-year Psychiatry intern at the Hospital Provincial de Castellón and doctoral candidate at the CEU Cardenal Herrera (CEU UCH) University of Valencia, along with his thesis directors, Gonzalo Haro and Ana Benito, have just published in journal Brain Science the final results of three year-long research where they have studied the effects of cocaine on patients diagnosed with schizophrenia or antisocial personality disorder.
Today, Insilico Medicine, Inc., a Rockville-based next-generation artificial intelligence company specializing in the application of deep learning for target identification, drug discovery and aging research announces the publication of a new research paper "Entangled Conditional Adversarial Autoencoder for de-novo Drug Discovery" in Molecular Pharmaceutics, the leading American Chemical Society journal covering research on the molecular mechanistic understanding of drug delivery and drug delivery systems
A Wayne State University researcher has received a combined $36,000 in grants from the Southeastern Michigan Health Association and Greater Cincinnati HealthBridge, Inc. to help determine the success of a Type 2 diabetes intervention program currently being piloted in southeast Michigan, greater Cincinnati and New Orleans.
› Verified 7 days ago
| Entity Name | Osf Multi-specialty Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922445527 PECOS PAC ID: 3678889789 Enrollment ID: O20150904000279 |
News Archive
Researchers at the University of Chicago have developed the first truly accurate mouse model of celiac disease. The animals have the same genetic and immune system characteristics as humans who develop celiac after eating gluten. This provides a vital research tool for developing and testing new treatments for the disease.
Alejandro Fuertes-Saiz, fourth-year Psychiatry intern at the Hospital Provincial de Castellón and doctoral candidate at the CEU Cardenal Herrera (CEU UCH) University of Valencia, along with his thesis directors, Gonzalo Haro and Ana Benito, have just published in journal Brain Science the final results of three year-long research where they have studied the effects of cocaine on patients diagnosed with schizophrenia or antisocial personality disorder.
Today, Insilico Medicine, Inc., a Rockville-based next-generation artificial intelligence company specializing in the application of deep learning for target identification, drug discovery and aging research announces the publication of a new research paper "Entangled Conditional Adversarial Autoencoder for de-novo Drug Discovery" in Molecular Pharmaceutics, the leading American Chemical Society journal covering research on the molecular mechanistic understanding of drug delivery and drug delivery systems
A Wayne State University researcher has received a combined $36,000 in grants from the Southeastern Michigan Health Association and Greater Cincinnati HealthBridge, Inc. to help determine the success of a Type 2 diabetes intervention program currently being piloted in southeast Michigan, greater Cincinnati and New Orleans.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vijaya Somaraju, MD 1905 E. Huebbe Parkway, Beloit Health System Inc, Beloit, WI 53511-1842 Ph: (608) 364-2200 | Vijaya Somaraju, MD 1905 E. Huebbe Parkway, Beloit Clinic, Beloit, WI 53511-1842 Ph: (608) 364-2240 |
News Archive
Researchers at the University of Chicago have developed the first truly accurate mouse model of celiac disease. The animals have the same genetic and immune system characteristics as humans who develop celiac after eating gluten. This provides a vital research tool for developing and testing new treatments for the disease.
Alejandro Fuertes-Saiz, fourth-year Psychiatry intern at the Hospital Provincial de Castellón and doctoral candidate at the CEU Cardenal Herrera (CEU UCH) University of Valencia, along with his thesis directors, Gonzalo Haro and Ana Benito, have just published in journal Brain Science the final results of three year-long research where they have studied the effects of cocaine on patients diagnosed with schizophrenia or antisocial personality disorder.
Today, Insilico Medicine, Inc., a Rockville-based next-generation artificial intelligence company specializing in the application of deep learning for target identification, drug discovery and aging research announces the publication of a new research paper "Entangled Conditional Adversarial Autoencoder for de-novo Drug Discovery" in Molecular Pharmaceutics, the leading American Chemical Society journal covering research on the molecular mechanistic understanding of drug delivery and drug delivery systems
A Wayne State University researcher has received a combined $36,000 in grants from the Southeastern Michigan Health Association and Greater Cincinnati HealthBridge, Inc. to help determine the success of a Type 2 diabetes intervention program currently being piloted in southeast Michigan, greater Cincinnati and New Orleans.
› Verified 7 days ago
Jordan Robert Hanrahan, Infectious Disease Medicare: Medicare Enrolled Practice Location: Beloit Health System Inc, 1969 W Hart Road, Beloit, WI 53511 Phone: 608-364-2293 Fax: 608-364-5525 | |
George T Jones, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1969 West Hart Road, Beloit Health System / Beloit Memorial Hospital, Beloit, WI 53511 Phone: 608-364-5971 Fax: 608-363-5737 | |
Steven S. Yang, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1905 E. Huebbe Parkway, Beloit, WI 53511 Phone: 608-364-1460 Fax: 608-363-7317 | |
William M Fitzgerald Ii, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1905 E. Huebbe Parkway, Beloit Health System Inc., Beloit, WI 53511 Phone: 608-364-2200 Fax: 608-363-7374 | |
Jennifer D. Dochee, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: Beloit Memorial Hospital, 1969 W. Hart Rd, Beloit, WI 53511 Phone: 608-364-5205 Fax: 608-363-7377 | |
Dr. Jaime Gonzalez, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1969 West Hart Rd, Beloit, WI 53511 Phone: 608-364-5011 Fax: 608-364-5452 |